Curated News
By: NewsRamp Editorial Staff
July 10, 2025
ADAP Advocacy Urges CMS to Exclude HIV Meds from Drug Price Negotiations
TLDR
- ADAP Advocacy's push for an HIV medication carve-out in Medicare negotiations could safeguard vital treatments, ensuring PLWHA maintain access to life-saving drugs without compromise.
- ADAP Advocacy has formally requested CMS to exclude HIV antiretroviral therapies from Medicare price negotiations, citing risks to treatment continuity and public health progress.
- Exempting HIV medications from Medicare price negotiations could preserve the 'treatment as prevention' strategy, protecting PLWHA and preventing new infections for a healthier future.
- ADAP Advocacy highlights the critical need to exempt HIV drugs from Medicare price talks to avoid jeopardizing decades of progress in HIV treatment and prevention.
Impact - Why it Matters
This news is crucial because it addresses the potential risks to the health and well-being of People Living with HIV/AIDS if their medications become part of Medicare's drug price negotiation program. Access to consistent and effective treatment is vital for managing HIV, preventing the virus from developing resistance, and reducing the spread of new infections. The advocacy's efforts highlight the broader implications of healthcare policy on vulnerable populations and the importance of safeguarding access to life-saving medications.
Summary
ADAP Advocacy has taken a significant step by submitting public comments to the Centers for Medicare and Medicaid Services (CMS), urging for a carve-out on HIV antiretroviral therapies under the Medicare Drug Price Negotiation Program. This move, rooted in the Inflation Reduction Act of 2022, highlights the critical concern for People Living with HIV/AIDS (PLWHA), should their medications be subject to price negotiations. Brandon M. Macsata, CEO of ADAP Advocacy, emphasizes the dire consequences of such negotiations, including the risk of patients losing access to vital treatments, which could lead to severe health complications and the potential for the virus to develop resistance to medications. The advocacy group's written testimony to the Centers for Medicare & Medicaid Services underscores the importance of maintaining access to HIV medications to continue the progress in combating the HIV epidemic through a 'treatment as prevention' approach.
ADAP Advocacy's mission focuses on enhancing the AIDS Drug Assistance Programs (ADAPs) and improving access to care for individuals living with HIV/AIDS. By collaborating with various stakeholders, including advocates, healthcare providers, and pharmaceutical companies, the organization aims to raise awareness and foster community collaboration to ensure that PLWHA receive the necessary treatments without compromise.
Source Statement
This curated news summary relied on content disributed by 24-7 Press Release. Read the original source here, ADAP Advocacy Urges CMS to Exclude HIV Meds from Drug Price Negotiations
